Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Julphar
Daiichi Sankyo
Cipla
US Department of Justice
Harvard Business School
Colorcon
Express Scripts
Johnson and Johnson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,658,590

« Back to Dashboard

Summary for Patent: 5,658,590
Title: Treatment of attention-deficit/hyperactivity disorder
Abstract:Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder.
Inventor(s): Heiligenstein; John H. (Indianapolis, IN), Tollefson; Gary D. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/371,341
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,658,590
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,658,590

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,658,590

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 222757 ➤ Try a Free Trial
Australia 4693896 ➤ Try a Free Trial
Australia 688665 ➤ Try a Free Trial
Brazil 9606903 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
McKinsey
UBS
Teva
Fish and Richardson
Boehringer Ingelheim
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.